Catalog Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Perforation (2513)
|
Event Date 01/24/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number:(b)(4).
|
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib) -paroxysmal ablation with a thermocool® smart touch® sf bi-directional navigation catheter and at the end of ablation phase the patient experienced cardiac perforation that required pericardiocentesis.During the afib case, a pericardial effusion was noticed.There was a drop in blood pressure in the patient.The pericardial effusion was confirmed by an ultrasound machine using a soundstar catheter.The medical intervention provided was a pericardiocentesis.The patient was reported to be in stable condition and "will be incubated overnight." the physician was unsure of what caused the pericardial effusion.However, the cardiac perforation was confirmed.No bwi product malfunction was noted.Patient improved / fully recovered but did require an extended hospitalization.Transeptal puncture was performed.Ablation was performed prior to noting the pericardial effusion.No evidence of steam pop.No error messages observed on biosense webster equipment during the procedure.
|
|
Manufacturer Narrative
|
On (b)(6) 2024, the bwi product analysis lab received the device for evaluation.The product investigation was subsequently completed.It was reported that a patient underwent an atrial fibrillation (afib) paroxysmal ablation with a thermocool® smart touch® sf bi-directional navigation catheter and at the end of ablation phase the patient experienced cardiac perforation that required pericardiocentesis.During the afib case, a pericardial effusion was noticed.There was a drop in blood pressure in the patient.The pericardial effusion was confirmed by an ultrasound machine using a soundstar catheter.The medical intervention provided was a pericardiocentesis.The patient was reported to be in stable condition and "will be incubated overnight." the physician was unsure of what caused the pericardial effusion.However, the cardiac perforation was confirmed.No bwi product malfunction was noted.Patient improved / fully recovered but did require an extended hospitalization.Device evaluation details: the device was returned to biosense webster (bwi) for evaluation.A visual inspection and revision of all features were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device 31185633l number, and no internal action related to the complaint was found during the review.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.Physician isn¿t sure what caused the pericardial effusion.No bwi product malfunction was noted.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|